Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
104402183 | 10440218 | 3 | F | 20131111 | 20160715 | 20140908 | 20160715 | EXP | US-BRISTOL-MYERS SQUIBB COMPANY-20119905 | BRISTOL MYERS SQUIBB | 44.97 | YR | M | Y | 81.63000 | KG | 20160715 | CN | JP | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
104402183 | 10440218 | 1 | PS | ABILIFY | ARIPIPRAZOLE | 1 | Unknown | U | 21436 | TABLET | |||||||||
104402183 | 10440218 | 2 | SS | ABILIFY MAINTENA | ARIPIPRAZOLE | 1 | Intramuscular | 06NOV13 | N | ABS0313 | 0 | 400 | MG | ||||||
104402183 | 10440218 | 3 | C | PROLIXIN DECANOATE | FLUPHENAZINE DECANOATE | 1 | Unknown | UNK | U | 0 | |||||||||
104402183 | 10440218 | 4 | C | DEPAKOTE | DIVALPROEX SODIUM | 1 | Unknown | U | 0 | ||||||||||
104402183 | 10440218 | 5 | C | PROLIXIN | FLUPHENAZINE HYDROCHLORIDE | 1 | Unknown | U | 0 | ||||||||||
104402183 | 10440218 | 6 | C | ILOPERIDONE | ILOPERIDONE | 1 | Unknown | U | 0 | ||||||||||
104402183 | 10440218 | 7 | C | KLONOPIN | CLONAZEPAM | 1 | Unknown | U | 0 | ||||||||||
104402183 | 10440218 | 8 | C | COGENTIN | BENZTROPINE MESYLATE | 1 | Unknown | U | 0 | ||||||||||
104402183 | 10440218 | 9 | C | ZYPREXA ZYDIS | OLANZAPINE | 1 | Unknown | U | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
104402183 | 10440218 | 1 | Product used for unknown indication |
104402183 | 10440218 | 2 | Schizoaffective disorder |
104402183 | 10440218 | 3 | Product used for unknown indication |
104402183 | 10440218 | 4 | Product used for unknown indication |
104402183 | 10440218 | 5 | Product used for unknown indication |
104402183 | 10440218 | 6 | Product used for unknown indication |
104402183 | 10440218 | 7 | Product used for unknown indication |
104402183 | 10440218 | 8 | Product used for unknown indication |
104402183 | 10440218 | 9 | Product used for unknown indication |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
104402183 | 10440218 | HO |
104402183 | 10440218 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
104402183 | 10440218 | Anxiety | |
104402183 | 10440218 | Drug hypersensitivity | |
104402183 | 10440218 | Hypomania | |
104402183 | 10440218 | Mania | |
104402183 | 10440218 | Schizoaffective disorder | |
104402183 | 10440218 | Speech disorder |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
104402183 | 10440218 | 2 | 20131009 | 0 | ||
104402183 | 10440218 | 3 | 20130718 | 0 |